Redhill Biophrma ADR (RDHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,620 | -7,180 | -4,480 | -1,970 | -10,320 |
| Depreciation Amortization | 20 | 10 | 10 | 6 | 20 |
| Accounts payable and accrued liabilities | 1,337 | N/A | N/A | N/A | N/A |
| Other Working Capital | 1,040 | 260 | 90 | 40 | 450 |
| Other Operating Activity | -207 | 930 | 510 | 174 | 3,060 |
| Operating Cash Flow | $-8,430 | $-5,980 | $-3,870 | $-1,750 | $-6,790 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 477 | N/A | N/A | N/A | N/A |
| PPE Investments | -10 | -10 | -9 | 70 | -8 |
| Sale Of Investment | 876 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -210 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -223 | 860 | 1,069 | 480 | 2,978 |
| Investing Cash Flow | $1,120 | $850 | $1,060 | $550 | $2,970 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,280 | N/A | N/A | N/A | N/A |
| Dividend Paid | 0 | 0 | 0 | 0 | 300 |
| Other Financing Activity | 0 | 1,440 | 170 | 110 | 6,250 |
| Financing Cash Flow | $2,280 | $1,440 | $170 | $110 | $6,550 |
| Exchange Rate Effect | 60 | 30 | 5 | 8 | 10 |
| Beginning Cash Position | 16,810 | 16,810 | 16,810 | 16,810 | 14,070 |
| End Cash Position | 11,850 | 13,160 | 14,170 | 15,720 | 16,810 |
| Net Cash Flow | $-4,960 | $-3,640 | $-2,630 | $-1,080 | $2,740 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,430 | -5,980 | -3,870 | -1,750 | -6,790 |
| Capital Expenditure | -14 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -8,444 | -5,980 | -3,870 | -1,750 | -6,790 |